RDIF agrees with India on production of 100 mln doses of Sputnik V - Chemical Industry - PRIME Business News Agency - All News Politics Economy Business Wire Financial Wire Oil Gas Chemical Industry Power Industry Metals Mining Pulp Paper Agro Commodities Transport Automobile Construction Real Estate Telecommunications Engineering Hi-Tech Consumer Goods Retail Calendar Our Features Interviews Opinions Press Releases

RDIF agrees with India on production of 100 mln doses of Sputnik V

MOSCOW, Apr 5 (PRIME) -- The Russian Direct Investment Fund (RDIF) agreed with Indian pharmaceutical company Panacea Biotec on production of 100 million doses of the Sputnik V anti-coronavirus vaccine annually, the fund said in a statement on Monday.

УThe RDIF and one of IndiaТs leading vaccines and medicines producer Panacea Biotec announce partnership for annual production of 100 million doses of the worldТs first-registered anti-coronavirus vaccine Sputnik V,Ф it said.

The vaccine will be supplied to the RDIFТs international partners, it added.

End %%as/jst%%

05.04.2021 15:21
 
 
Share |
To report an error select text and press Ctrl+Enter
 
 
Central Bank Official Rate
1W 1M 1Y
USD
EUR 90.4602 -1.7705 17 apr
USD 75.5535 -1.4273 17 apr
Stock Market Indices
1D 1W 1M 1Y
MICEX
micex 3580.70 +0.34 16:42 16 apr
Stock Quotes in RUR
1D 1W 1M 1Y
GAZP
gazp 234.63 -0.29 23:49 16 apr
lkoh 6054.50 -1.30 23:49 16 apr
rosn 556.50 +0.80 23:49 16 apr
sber 283.72 -1.20 23:49 16 apr
MICEX Ruble Trading
1D 1W 1M 1Y
USDTD
EURTD 90.9300 -1.3125 14:59 16 apr
USDTD 76.2475 +0.6525 17:44 16 apr